These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1122 related items for PubMed ID: 15036488

  • 1. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 2. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar 15; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 3. Relationship of bone turnover to bone density and fractures.
    Melton LJ, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL.
    J Bone Miner Res; 1997 Jul 15; 12(7):1083-91. PubMed ID: 9200008
    [Abstract] [Full Text] [Related]

  • 4. Biochemical markers as predictors of rates of bone loss after menopause.
    Rogers A, Hannon RA, Eastell R.
    J Bone Miner Res; 2000 Jul 15; 15(7):1398-404. PubMed ID: 10893690
    [Abstract] [Full Text] [Related]

  • 5. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2007 Jun 15; 22(6):799-807. PubMed ID: 17352648
    [Abstract] [Full Text] [Related]

  • 6. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB.
    J Bone Miner Res; 2005 Jun 15; 20(6):962-70. PubMed ID: 15883636
    [Abstract] [Full Text] [Related]

  • 7. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF, Geyikli I, Yazgan P, Celik A.
    Arch Gynecol Obstet; 2006 Jun 15; 274(3):133-7. PubMed ID: 16532321
    [Abstract] [Full Text] [Related]

  • 8. Cross-sectional evaluation of bone metabolism in men.
    Szulc P, Garnero P, Munoz F, Marchand F, Delmas PD.
    J Bone Miner Res; 2001 Sep 15; 16(9):1642-50. PubMed ID: 11547833
    [Abstract] [Full Text] [Related]

  • 9. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E.
    J Obstet Gynaecol Res; 2009 Feb 15; 35(1):152-9. PubMed ID: 19215563
    [Abstract] [Full Text] [Related]

  • 10. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
    Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J.
    J Bone Miner Res; 1999 Sep 15; 14(9):1583-95. PubMed ID: 10469288
    [Abstract] [Full Text] [Related]

  • 11. Is bone turnover a determinant of bone mass in rheumatoid arthritis?
    Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B.
    J Rheumatol; 1998 Dec 15; 25(12):2339-44. PubMed ID: 9858427
    [Abstract] [Full Text] [Related]

  • 12. Dose-response relationships between energy availability and bone turnover in young exercising women.
    Ihle R, Loucks AB.
    J Bone Miner Res; 2004 Aug 15; 19(8):1231-40. PubMed ID: 15231009
    [Abstract] [Full Text] [Related]

  • 13. Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis.
    Jiang LS, Zhang ZM, Jiang SD, Chen WH, Dai LY.
    J Bone Miner Res; 2008 Apr 15; 23(4):475-83. PubMed ID: 18052758
    [Abstract] [Full Text] [Related]

  • 14. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E.
    Scand J Gastroenterol; 2003 Mar 15; 38(3):320-7. PubMed ID: 12737449
    [Abstract] [Full Text] [Related]

  • 15. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD.
    J Bone Miner Res; 1996 Oct 15; 11(10):1531-8. PubMed ID: 8889854
    [Abstract] [Full Text] [Related]

  • 16. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I, Larijani B, Vahdat K, Assadi M, Jafari SM, Ahmadi E, Movahed A, Moradhaseli F, Sanjdideh Z, Obeidi N, Amiri Z.
    Menopause; 2009 Oct 15; 16(5):950-5. PubMed ID: 19387415
    [Abstract] [Full Text] [Related]

  • 17. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
    Delmas PD, Licata AA, Reginster JY, Crans GG, Chen P, Misurski DA, Wagman RB, Mitlak BH.
    Bone; 2006 Aug 15; 39(2):237-43. PubMed ID: 16563890
    [Abstract] [Full Text] [Related]

  • 18. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
    Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, Prince RL, Stewart G, Stuckey B, Will RK, Retallack RW, Price RI, Ward L.
    J Bone Miner Res; 1996 Aug 15; 11(8):1176-84. PubMed ID: 8854254
    [Abstract] [Full Text] [Related]

  • 19. Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women.
    Cosman F, Nieves J, Woelfert L, Shen V, Lindsay R.
    J Bone Miner Res; 1998 Jun 15; 13(6):1051-5. PubMed ID: 9626638
    [Abstract] [Full Text] [Related]

  • 20. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL, Loft AG, Møller N, Weeke J, Eriksen EF, Mosekilde L, Charles P.
    J Bone Miner Res; 1997 Jan 15; 12(1):78-88. PubMed ID: 9240729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.